封面
市場調查報告書
商品編碼
1417543

Olanzapine市場報告:至2030年的趨勢、預測與競爭分析

Olanzapine Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

Olanzapine趨勢和預測

預計到2030年,全球Olanzapine市場預計將達到 19 億美元,2024年至2030年年複合成長率為 2.1%。該市場的主要促進因素是雙相情感障礙治療的增加、神經系統疾病盛行率的上升以及政府對醫療保健行業基礎設施發展的資助增加。全球Olanzapine市場的未來看起來充滿希望,雙極性情感障礙和思覺失調症市場充滿機會。

Olanzapine市場洞察

Lucintel 認為,在預測期內,口服藥物將繼續成為較大的細分市場,因其具有非侵入性、患者依從性高、易於使用且不需要特殊的無菌條件等廣泛使用,預計口服藥物在預測期內將繼續成為較大的細分市場。

由於北美思覺失調症盛行率不斷上升,對Olanzapine製劑的需求不斷增加,在預測期內北美仍將是最大的地區。

常問問題

Q1.市場規模有多大?

A1.到2030年,Olanzapine的全球市場預計將達到19億美元。

Q2.市場成長預測如何?

A2.2024年至2030年,Olanzapine的全球市場預計將以2.1%的年複合成長率成長。

Q3.影響市場成長的主要促進因素有哪些?

A3.該市場的主要驅動力是雙相情感障礙治療的增加、神經系統疾病盛行率的上升以及政府對醫療保健行業基礎設施發展的資助增加。

Q4.市場的主要細分市場是什麼?

A4.由於雙極性情感障礙和思覺失調症市場的機會,全球Olanzapine市場的未來充滿希望。

Q5.市場上主要企業有哪些?

A5.生產Olanzapine的主要企業如下。

  • Dr ready's laboratory
  • Watson pharmaceuticals
  • Lilly
  • Hamson pharmaceuticals
  • Sun pharmaceuticals
  • Sandoz pharmaceuticals
  • Torrent pharmaceuticals

Q6.未來最大的細分市場是什麼?

A6.口服藥物因其非侵入性、患者依從性高、使用方便且不需要特殊的無菌條件而廣泛使用,預計口服藥物在預測期內仍將佔較大佔有率。

Q7.預計未來五年哪個地區將成為最大的市場?

A7.由於該地區思覺失調症盛行率不斷上升,對Olanzapine治療藥物的需求增加,因此在預測期內,北美仍是最大的地區。

Q8.可以客製化報告嗎?

A8.是的,Lucintel 提供 10%的客製化服務,無需額外付費。

目錄

第1章 執行摘要

第2章 全球Olanzapine市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球Olanzapine市場趨勢(2018-2023)與預測(2024-2030)
  • 依給藥途徑分類的全球Olanzapine市場
    • 口服
    • 胃腸外
  • 全球Olanzapine市場應用
    • 躁鬱症
    • 思覺失調症
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球Olanzapine市場(依地區)
  • 北美Olanzapine市場
  • 歐洲Olanzapine市場
  • 亞太地區Olanzapine市場
  • 其他地區Olanzapine市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按途徑的全球Olanzapine市場成長機會
    • 依應用分類的全球Olanzapine市場成長機會
    • 依地區分類的全球Olanzapine市場成長機會
  • 全球Olanzapine市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球Olanzapine市場產能擴張
    • 全球Olanzapine市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • Dr ready's laboratory
  • Watson pharmaceuticals
  • Lilly
  • Hamson pharmaceuticals
  • Sun pharmaceuticals
  • Sandoz pharmaceuticals
  • Torrent pharmaceuticals
簡介目錄

Olanzapine Trends and Forecast

The future of the global olanzapine market looks promising with opportunities in the bipolar disorder and schizophrenia markets. The global olanzapine market is expected to reach an estimated $1.9 billion by 2030 with a CAGR of 2.1% from 2024 to 2030. The major drivers for this market are the increasing use of bipolar therapy, rise in the prevalence of neurological conditions, and growth in government funding for infrastructure upgrades in the healthcare industry.

A more than 150-page report is developed to help in your business decisions.

Olanzapine by Segment

The study includes a forecast for the global olanzapine by route of administration, application, and region.

Olanzapine Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Oral
  • Parenteral

Olanzapine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Bipolar Disorder
  • Schizophrenia
  • Others

Olanzapine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Olanzapine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies olanzapine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the olanzapine companies profiled in this report include-

  • Dr ready's laboratory
  • Watson pharmaceuticals
  • Lilly
  • Hamson pharmaceuticals
  • Sun pharmaceuticals
  • Sandoz pharmaceuticals
  • Torrent pharmaceuticals

Olanzapine Market Insights

Lucintel forecasts that oral will remain the larger segment over the forecast period because the oral medications are widely used as they are noninvasive, have high patient compliance, are easy to use, and do not require any special sterile conditions.

North America will remain the largest region over the forecast period due to the increase in demand for olanzapine medications owing to the growth in the prevalence of schizophrenia in this region.

Features of the Global Olanzapine Market

Market Size Estimates: Olanzapine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Olanzapine market size by route of administration, application, and region in terms of value ($B).

Regional Analysis: Olanzapine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different route of administration, application, and regions for the olanzapine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the olanzapine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the olanzapine market size?

Answer: The global olanzapine market is expected to reach an estimated $1.9 billion by 2030.

Q2. What is the growth forecast for olanzapine market?

Answer: The global olanzapine market is expected to grow with a CAGR of 2.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the olanzapine market?

Answer: The major drivers for this market are the increasing use of bipolar therapy, rise in the prevalence of neurological conditions, and growth in government funding for infrastructure upgrades in the healthcare industry.

Q4. What are the major segments for olanzapine market?

Answer: The future of the global olanzapine market looks promising with opportunities in the bipolar disorder and schizophrenia markets.

Q5. Who are the key olanzapine market companies?

Answer: Some of the key olanzapine companies are as follows.

  • Dr ready's laboratory
  • Watson pharmaceuticals
  • Lilly
  • Hamson pharmaceuticals
  • Sun pharmaceuticals
  • Sandoz pharmaceuticals
  • Torrent pharmaceuticals

Q6. Which olanzapine market segment will be the largest in future?

Answer: Lucintel forecasts that oral will remain the larger segment over the forecast period because the oral medications are widely used as they are noninvasive, have high patient compliance, are easy to use, and do not require any special sterile conditions.

Q7. In olanzapine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the increase in demand for olanzapine medications owing to the growth in the prevalence of schizophrenia in this region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the olanzapine market by route of administration (oral and parenteral), application (bipolar disorder, schizophrenia, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Olanzapine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Olanzapine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Olanzapine Market by Route of Administration
    • 3.3.1: Oral
    • 3.3.2: Parenteral
  • 3.4: Global Olanzapine Market by Application
    • 3.4.1: Bipolar disorder
    • 3.4.2: Schizophrenia
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Olanzapine Market by Region
  • 4.2: North American Olanzapine Market
    • 4.2.2: North American Olanzapine Market by Application: Bipolar disorder, Schizophrenia, and Others
  • 4.3: European Olanzapine Market
    • 4.3.1: European Olanzapine Market by Route of Administration: Oral and Parenteral
    • 4.3.2: European Olanzapine Market by Application: Bipolar disorder, Schizophrenia, and Others
  • 4.4: APAC Olanzapine Market
    • 4.4.1: APAC Olanzapine Market by Route of Administration: Oral and Parenteral
    • 4.4.2: APAC Olanzapine Market by Application: Bipolar disorder, Schizophrenia, and Others
  • 4.5: ROW Olanzapine Market
    • 4.5.1: ROW Olanzapine Market by Route of Administration: Oral and Parenteral
    • 4.5.2: ROW Olanzapine Market by Application: Bipolar disorder, Schizophrenia, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Olanzapine Market by Route of Administration
    • 6.1.2: Growth Opportunities for the Global Olanzapine Market by Application
    • 6.1.3: Growth Opportunities for the Global Olanzapine Market by Region
  • 6.2: Emerging Trends in the Global Olanzapine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Olanzapine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Olanzapine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Dr ready's laboratory
  • 7.2: Watson pharmaceuticals
  • 7.3: Lilly
  • 7.4: Hamson pharmaceuticals
  • 7.5: Sun pharmaceuticals
  • 7.6: Sandoz pharmaceuticals
  • 7.7: Torrent pharmaceuticals